The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasis (vol 1, pg 1, 2017)

被引：0

|

作者：

Yiu, Z. Z.

Warren, R. B.

机构：

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2017年 / 26卷 / 02期

关键词：

D O I：

10.1080/13543784.2017.1280117

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：263 / 263

页数：1

相关论文

共 50 条

[1] The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasis
Yiu, Zenas Z. N.
Warren, Richard B.
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (02) : 243 - 249
[2] Treatment of psoriasis vulgaris exacerbated by immunotherapy with the interleukin-23 (IL-23) antibody tildrakizumab
Koutra, E.
Angela, Y.
Gutzmer, R.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 88 - 88
[3] Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
Koutruba, Nora
Emer, Jason
Lebwohl, Mark
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 123 - 141
[4] Interleukin-23 blockade: another breakthrough in the treatment of psoriasis
Lebwohl, Mark
LANCET, 2019, 394 (10198): : 544 - 546
[5] The utility of interleukin-23 intraclass switching in the treatment of plaque psoriasis: a retrospective review of 43 cases
Hren, M. Grace
Miriyala, Sreekar
Khattri, Saakshi
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 50 (01) : 137 - 140
[6] Erythema multiforme during treatment with interleukin-12 and interleukin-23 inhibitor
Bogucki, Pawel
Downs, Anthony
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB199 - AB199
[7] The role of IL 23 in the treatment of psoriasis (vol 13, pg 525, 2017)
Puig, L.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (06) : IX - IX
[8] Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis (vol 34, pg 39, 2020)
Egeberg, A.
Andersen, Y. M. F.
Halling-Overgaard, A. -S.
Alinaghi, F.
Thyssen, J. P.
Burge, R.
Mallbris, L.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (09) : 2156 - 2156
[9] Re: Increased expression of interleukin-23 associated with progression of colorectal cancer (vol 115, pg 208, 2017)
Hu, Wan-Hsiang
Chen, Hong-Hwa
Yen, Shao-Lun
Huang, Hsuan-Ying
Hsiao, Chang-Chun
Chuang, Jiin-Haur
JOURNAL OF SURGICAL ONCOLOGY, 2018, 118 (04) : 723 - 723
[10] Inhibition of interleukin-12 and/or interleukin-23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?
Ergen, Elizabeth N.
Yusuf, Nabiha
EXPERIMENTAL DERMATOLOGY, 2018, 27 (07) : 737 - 747

← 1 2 3 4 5 →